论文期刊

取消

高级检索

检索历史清除

首页> Journal of controlled release : official journal of the Controlled Release Society> Tumor-specific delivery of gemcitabine with activatable liposomes.

Tumor-specific delivery of gemcitabine with activatable liposomes.

导出 OA

翻译打印收藏纠错

作者： Samantha T,Tucci ^[1] ; Azadeh,Kheirolomoom ^[2] ; Elizabeth S,Ingham ^[1] ; Lisa M,Mahakian ^[1] ; Sarah M,Tam ^[1] ; Josquin,Foiret ^[3] ; Neil E,Hubbard ^[4] ; Alexander D,Borowsky ^[4] ; Mo,Baikoghli ^[5] ; R Holland,Cheng ^[5] ; Katherine W,Ferrara ^[6]

作者单位： University of California, Davis, Department of Biomedical Engineering, Davis, CA 95616, USA. ^[1] University of California, Davis, Department of Biomedical Engineering, Davis, CA 95616, USA; Stanford University, Department of Radiology, 3165 Porter Drive, Palo Alto, CA 94304, USA. ^[2] Stanford University, Department of Radiology, 3165 Porter Drive, Palo Alto, CA 94304, USA. ^[3] University of California, Davis, Center for Comparative Medicine, Davis, CA 95616, USA. ^[4] University of California, Davis, Department of Molecular and Cellular Biology, Davis, CA 95616, USA. ^[5] Stanford University, Department of Radiology, 3165 Porter Drive, Palo Alto, CA 94304, USA. Electronic address: kwferrar@stanford.edu. ^[6]

关键词 Breast cancer Gemcitabine Pancreatic ductal adenocarcinoma Temperature-sensitive liposome Ultrasound

主题词动物(Animals);抗代谢药, 抗肿瘤(Antimetabolites, Antineoplastic);乳腺肿瘤(Breast Neoplasms);细胞系, 肿瘤(Cell Line, Tumor);迟效制剂(Delayed-Action Preparations);脱氧胞苷(Deoxycytidine);药物释放系统(Drug Delivery Systems);女(雌)性(Female);人类(Humans);高温, 诱发(Hyperthermia, Induced);脂质体(Liposomes);小鼠(Mice);小鼠, 近交C57BL(Mice, Inbred C57BL);胰腺肿瘤(Pancreatic Neoplasms);温度(Temperature)

DOI 10.1016/j.jconrel.2019.07.014

PMID 31301340

发布时间 2022-12-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of controlled release

277-288页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

Journal of controlled release

277-288页

相关期刊

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷